METOPIRONE Capsules Ref.[8619] Active ingredients: Mepyrapone

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2016  Publisher: Laboratoire HRA Pharma, 15 rue Béranger, 75003, Paris, France

Product name and form

Metopirone Capsules 250mg.

Pharmaceutical Form

Yellowish-white, oblong, opaque, soft gelatin capsules printed ‘HRA’ on one side in red ink.

Qualitative and quantitative composition

Metyrapone BP 250mg.

Active Ingredient Description
Mepyrapone
List of Excipients

Capsule contents:

Glycerin
Polyethylene glycol 400
Polyethylene glycol 4000
Water

Capsule shell:

Sodium ethylparaben
Ethyl vanillin
Gelatin
Glycerin 85%
P-methoxy acetophenone
Sodium propylparaben
Titanium oxide (E171)

Pack sizes and marketing

High density polyethylene bottles of 100 capsules with child resistant polypropylene closure.

Marketing authorization holder

Laboratoire HRA Pharma, 15 rue Béranger, 75003, Paris, France

Marketing authorization dates and numbers

PL 17836/0007

25 June 1998

Drugs

Drug Countries
METOPIRONE Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Poland, Romania, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈